Lab-on-a-Chip Device Market Research Report – Forecast to 2032

Lab-on-a-Chip Device Market Research Report Information By Product (Instruments, Reagents and Consumables), By Technology (Microarrays, Microfluidics, Tissue Biochip, and Others), By Application (Genomics, Proteomics, Point of Care Diagnostics, Drug Discovery, and Others), By End User (Hospitals & Clinics, Biotechnology and Pharmaceutical Companies, Forensic Laboratories, Diagnostic Centers, and Academic & Research Institutes), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

ID: MRFR/MED/4754-HCR | 100 Pages | Author: Kinjoll Dey | February 2024         

Global Lab-on-a-Chip Device Market Overview


Lab-on-a-Chip Device Market Size was valued at USD 5.5 Billion in 2022. The Lab-on-a-Chip Device market industry is projected to grow from USD 6.0 Billion in 2023 to USD 11.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.90% during the forecast period (2023 - 2032). A rise in the incidence of both chronic and infectious diseases, as well as an expansion of genomic and proteomic research applications, are all contributing factors in the rise of cancer, are the key market drivers enhancing the market growth.


Lab-on-a-Chip Device Market


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Lab-on-a-Chip Device Market Trends



  • Increase in the prevalence of chronic and infectious diseases is driving the market growth


The market for chips in labs has grown as a result of rising chronic diseases, increased uses of genomics and proteomics in cancer research, and rising revenues. The market for lab on a chip has been further fueled by the rise in demand for personalised treatment. The pattern is anticipated to continue, and this technology's revenue will increase. The market for lab-on-a-chip is anticipated to have increased revenue growth as a result of the rising incidence of cancer in several countries. It aids in the early detection of oral cancer pathogens as well as the detection of swine flu, malaria, the Zika virus, and the Ebola virus. The lab and ship technology is being investigated for numerous applications in nations like North America, Asia, and Europe.


The market for labs and ships has expanded as a result of increased research and development investments by various governments. A need for lab on chips has also been generated by increased investments in personalised medicine and life sciences. The development of the market is also being fueled by several alliances and collaborations for creating cutting-edge lab ownership solutions. The ability of labs and chips to detect early pathology through the application of advanced technologies will propel the development of this technology.


Excellent assay sensitivity, parallelization, ergonomics, waste minimization, and other features are all part of LoC technology. This technology, which facilitates sample handling, delivers correct results quickly, and acts as a market growth driver, is primarily driven by the medical industry for the identification of various disorders. Additionally, the market for lab-on-a-chip will see new opportunities during the forecast period of 2022-2029 due to the growth in small device demand, biosensor and biomarker research, fabrication technology, and economic viability.


Lab-on-a-chip systems are characterised by the interdisciplinary integration of multiple disciplines and the simplification of laboratory procedures. Other areas of healthcare, like as stem cell, medication delivery, synthetic biology, and environmental monitoring, are beginning to use the high level of integration needed to develop LOC devices. Chronic diseases are spreading across the globe. A rapidly increasing  elderly population and changes in societal lifestyle are further factors causing an increase in frequent and expensive long-term health issues. The application of lab-on-a-chip in the detection of infectious diseases and chronic illnesses is one of the other significant factors boosting the market for these devices.


LoC is becoming more and more common in medicine for the diagnosis of many illnesses and infections, including HIV infections and chronic illnesses, as well as in botany. This is expected to advance the market. LoC devices are quite popular due to benefits including simple mobility, automated sample processing, and reconfigurability. LoC devices are perfect for point-of-care diagnostics since they provide quick and accurate results. Thus, driving the Lab-on-a-Chip Device market revenue.


Lab-on-a-Chip Device Market Segment Insights


Lab-on-a-Chip Device Product Insights


The  Lab-on-a-Chip Device market segmentation, based on Product, includes instruments, reagents and consumables. Instruments segment dominated the  market in 2022. The increased use of biochip and bio-array technologies is to blame for this. In addition to the necessary chips, the use of lab-on-a-chip and microarrays in the lab also requires the necessary instrumentation, such as analyzers and support kits. Due to the rise in demand for reagents and consumables, the Reagents and Consumables Segment is anticipated to experience considerable growth in the near future.


Lab-on-a-Chip Device Technology Insights


The  Lab-on-a-Chip Device market segmentation, based on Technology, includes microarrays, microfluidics, tissue biochip, and others. The microfluidics segment dominated the  market in 2022. The transition from traditional laboratory practises to a lab on chips is the result of greater application of microfluidics. Microfluidics has been utilised widely to produce a wide range of consumer goods, and it is anticipated to have a wide range of applications. They provide a good return on investment and aid in lowering cost management errors.


Lab-on-a-Chip Device Application Insights


The  Lab-on-a-Chip Device market segmentation, based on Application, includes genomics, proteomics, point of care diagnostics, drug discovery, and others. Point of care diagnostics segment dominated the  Lab-on-a-Chip Device market in 2022. This is explained by the rise in clinical uses of LOC. It is an automated, miniature laboratory system that is utilised both inside and outside of hospitals for various clinical purposes.


Lab-on-a-Chip Device End User Insights


The  Lab-on-a-Chip Device market segmentation, based on End User, includes hospitals & clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostic centers, and academic & research institutes. The hospital & clinics segment dominated the  Lab-on-a-Chip Device market in 2022. The increased use of biochip and bio-array technologies is to blame for this. Numerous biological and other analytical applications make use of LOC devices.


Figure 1  Lab-on-a-Chip Device Market, by End User, 2022 & 2032 (USD Billion)
Lab-on-a-Chip Device Market, by End User, 2022 & 2032


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Lab-on-a-Chip Device Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Lab-on-a-Chip Device Market dominated this market in 2022 (45.80%). This is due to the growing use of genetic engineering and molecular biology techniques, as well as the rising incidence of infectious diseases. The development of cutting-edge medical treatment options, rising demand for portable devices, and an increase in the number of genomic and proteomics research labs are additional factors that are likely to support the growth of the Lab-on-a-Chip device market in the North American region. Further, the U.S. Lab-on-a-Chip Device market held the largest market share, and the Canada Lab-on-a-Chip Device market was the fastest growing market in the North America region.


Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2  LAB-ON-A-CHIP DEVICE MARKET SHARE BY REGION 2022 (USD Billion)
LAB-ON-A-CHIP DEVICE MARKET SHARE BY REGION 2022


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe Lab-on-a-Chip Device market accounted for the healthy market share in 2022. This is a result of important motivating elements such the booming medical device sector, supportive government programmes to boost life sciences and clinical research, and rising per capita income levels. Further, the German Lab-on-a-Chip Device market held the largest market share, and the U.K Lab-on-a-Chip Device market was the fastest growing market in the European region


The Asia Pacific Lab-on-a-Chip Device market is expected to register significant growth from 2023 to 2032. This is because healthcare technology is adapting more quickly, there are more people with chronic and infectious diseases, more government measures to reform healthcare, and more research projects on environmental issues. Moreover, China’s Lab-on-a-Chip Device market held the largest market share and the Indian Lab-on-a-Chip Device market was the fastest growing market in the Asia-Pacific region.


Lab-on-a-Chip Device Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Lab-on-a-Chip Device market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Lab-on-a-Chip Device industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the  Lab-on-a-Chip Device industry to benefit clients and increase the market sector. In recent years, the Lab-on-a-Chip Device industry has offered some of the most significant advantages to medicine. Major players in the Lab-on-a-Chip Device market, including Becton, Dickinson and Company, Agilent Technologies Inc., Danaher Corporation, Bio-Rad Laboratories, Abbott Laboratories, Hoffmann-La, Roche AG, PerkinElmer Inc., IDEX Corporation, Thermo Fisher Scientific Inc., Cepheid Inc., and Biacore AB, are attempting to increase market demand by investing in research and development Products.


Transfusion diagnostic products are created and manufactured by Quotient Limited. The business offers transfusion diagnostics, also known as blood grouping and serological disease screening assays. For the MosaiQ Extended Immunohematology (IH) Microarray, Quotient Ltd. received the Conformite Europeenne (CE) Mark in March 2022. The European Medical Devices Directive (EMDD) standards are met by the Extended IH Microarray, according to the CE marking.


Optical genome mapping (OGM) is a genomics service offered by Bionano Genomics, Inc. for genome analysis. The business provides medical professionals that specialise in the treatment of patients with genetic problems, such as paediatric neurodevelopmental disorders, including autism spectrum disorders, with diagnostic services. It promotes and offers for sale the Saphyr system, which provides OGM data to allow for the very accurate and sensitive detection of all types of structural variation. Patients with clinical manifestations that are consistent with autism spectrum disorder and other neurodevelopmental impairments can receive diagnostic testing from its Lineagen division. It provides a platform-neutral software solution through its BioDiscovery business that combines sequencing and microarray data in order to analyse, visualise, interpret, and report copy number variants, single-nucleotide variants, and the absence of heterozygosity across the genome in a single consolidated view. The release of version 6.1 of BioDiscovery's NxClinical software for genome analysis, featuring features for visualisation, interpretation, and reporting of next-generation sequencing data in hereditary illnesses and cancer, was announced by Bionano Genomics Inc. in December 2021.


Key Companies in the Lab-on-a-Chip Device market include



  • Becton, Dickinson and Company

  • Agilent Technologies Inc.

  • Danaher Corporation

  • Bio-Rad Laboratories

  • Abbott Laboratories

  • Hoffmann-La Roche AG

  • PerkinElmer Inc.

  • IDEX Corporation

  • Thermo Fisher Scientific Inc.

  • Cepheid Inc.

  • Biacore AB


Lab-on-a-Chip Device Industry Developments


November 2021 An investment of USD 1.8 million was made public by Parallel Fluidics to make microfluidic development more accessible.


In April 2021 The proprietary COVID-19 multiplexed viral diagnostic test, DetectX-Rv, has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), according to PathogenDx Inc.


Lab-on-a-Chip Device Market Segmentation


Lab-on-a-Chip Device Product Outlook



  • Instruments

  • Reagents

  • Consumables


Lab-on-a-Chip Device Technology Outlook



  • Microarrays

  • Microfluidics

  • Tissue Biochip

  • Others


Lab-on-a-Chip Device Application Outlook



Lab-on-a-Chip Device End User Outlook



  • Hospitals & Clinics

  • Biotechnology and Pharmaceutical Companies

  • Forensic Laboratories

  • Diagnostic Centers

  • Academic & Research Institutes


Lab-on-a-Chip Device Regional Outlook



  • North America

    • US.

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Report Scope:

Lab-on-a-Chip Device Report Scope
Report Attribute/Metric Details
Market Size 2022 USD 5.5 Billion
Market Size 2023 USD 6.0 Billion
Market Size 2032 USD 11.2 Billion
Compound Annual Growth Rate (CAGR) 4.90% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Technology, Application, End User, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Becton, Dickinson and Company, Agilent Technologies Inc., Danaher Corporation, Bio-Rad Laboratories, Abbott Laboratories, Hoffmann-La, Roche AG, PerkinElmer Inc., IDEX Corporation, Thermo Fisher Scientific Inc., Cepheid Inc., and Biacore AB
Key Market Opportunities Improved preference for automated lab-on-a-chip practices
Key Market Dynamics Increase in the prevalence of chronic and infectious diseases and expanding applications of genomics and proteomics in cancer research




Frequently Asked Questions (FAQ) :

The  Lab-on-a-Chip Device market size was valued at USD 5.5 Billion in 2022.

The  market is projected to grow at a CAGR of 4.90% during the forecast period, 2023-2032.

The key players in the market are Becton, Dickinson and Company, Agilent Technologies Inc., Danaher Corporation, Bio-Rad Laboratories, Abbott Laboratories, Hoffmann-La, Roche AG, PerkinElmer Inc., IDEX Corporation, Thermo Fisher Scientific Inc., Cepheid Inc., and Biacore AB

The Instruments Product dominated the market in 2022.

The Microfluidics Technology had the largest share in the market.

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid